Purchase Order 75H70526P00026
- Not listed
- The Indian Health Service awarded a Delivery Order valued at $276,833.92 to Cepheid Inc. for the period of July 1, 2025 through June 30, 2026 under a CLSU Task Order vehicle. This firm fixed-price delivery order, issued on July 2, 2025, with no set-aside designation, will be performed at a facility in Cass Lake, Minnesota. Cepheid, headquartered in Sunnyvale, California, is a leading manufacturer of advanced molecular diagnostic systems and reagents specializing in infectious disease...
- The Indian Health Service awarded Cepheid Inc. a firm fixed-price purchase order valued at $1.49M on February 8, 2024, for laboratory supplies and testing equipment through September 2026. The contract covers an as-needed supply of diagnostic reagents, test kits, and microbiology supplies compatible with the Cepheid GeneXpert analyzer platform, including COVID-19 testing capabilities. Performance will occur at the Indian Health Service facility in Chinle, Arizona. This award carries no small...
- Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, was awarded a delivery order valued at $242,163.20 by the Indian Health Service (IHS) for Option Year Two of a contract covering laboratory supplies and testing services. The award, issued on July 2, 2024, covers the period from September 1, 2024, through August 31, 2025, with an ultimate completion date of August 31, 2028. The contract utilizes a firm fixed-price pricing model with no set-aside designation and is...
- The Indian Health Service awarded a purchase order to Cepheid Inc. for clinical laboratory supplies with a ceiling value of $679,320 under a firm fixed-price contract. The award, announced on May 15, 2024, covers a performance period from January 1, 2024 through December 31, 2024, with an ultimate completion date of May 14, 2025. This contract modification represents a closeout action and includes no set-aside designation. Cepheid, a molecular diagnostics manufacturer based in Sunnyvale,...
- The Indian Health Service awarded a purchase order to Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, on October 16, 2025. The contract, valued at $260,025, runs from October 19, 2025, through October 18, 2026, with an ultimate completion date of October 18, 2030. Utilizing firm fixed-price pricing with no set-aside designation, this purchase order will be performed in Parker, Arizona, and represents one of five related contract actions awarded under...
- The Indian Health Service awarded a firm fixed-price delivery order to Cepheid Inc. valued at $323,496 for the period July 1, 2025 through June 30, 2026. This task order, which carries no set-aside designation, will be performed in Red Lake, Minnesota. As a leading manufacturer of molecular diagnostic solutions, Cepheid will deliver diagnostic equipment, reagents, and associated services to support clinical testing capabilities at the IHS facility, consistent with the company's established...
- The Indian Health Service awarded Cepheid Inc. a delivery order valued at $1.76M under the agency's Multiple Award Schedule contract for molecular diagnostic testing supplies and equipment repair services. This Modification 4 exercise of Option 2 covers the period from January 1, 2024, through December 31, 2024, with an ultimate completion date of March 31, 2029. The delivery order, structured as a firm fixed-price contract with no set-aside designation, will be performed at Cepheid's...
- The Indian Health Service (IHS) awarded a $45,900 firm fixed-price purchase order to Cepheid Inc. on December 1, 2025, for molecular diagnostic solutions with a completion date of November 30, 2030. The contract, which carries no set-aside designation, will be performed in Tohatchi, New Mexico. Cepheid, a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents, will deliver diagnostic testing capabilities to support IHS healthcare operations. The company...
- Cepheid Inc. received a $756,310 firm fixed-price purchase order from the Indian Health Service (IHS) for molecular diagnostic testing supplies, specifically Cepheid 4PLEX PLUS and COVID-19 testing kits including XP3COV2/FLU/RSV-10 and XP3SARS-COV2-10 products or approved equivalents, to support clinical laboratory operations at the Zuni, New Mexico IHS facility. The contract, awarded on August 26, 2022, extends through August 31, 2027, and represents IHS's continued reliance on Cepheid's...
- The Indian Health Service (IHS) awarded a $204,000 firm fixed-price purchase order to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California, on December 31, 2025. The contract covers reagent testing kits for the IHS laboratory department, with an ultimate completion date of December 31, 2030. This award reflects no set-aside designation and represents a continuation of Cepheid's established relationship as a provider of molecular diagnostic...
The Indian Health Service awarded a $25,025.20 firm fixed-price purchase order to Cepheid Inc. for lab supplies on April 21, 2026, with completion targeted for June 30, 2026. This order covers invoices #9001936012 and #9001970129 and will be performed at the Cass Lake, Minnesota facility. The contract carries no set-aside designation, reflecting Cepheid's competitive standing in federal molecular diagnostics procurement. This purchase order represents a routine supply acquisition within Cepheid's broader portfolio of diagnostic supply agreements with the Indian Health Service. Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, serves as a primary federal supplier of diagnostic solutions including its GeneXpert diagnostic platform and associated reagents and test kits. The company has established significant relationships across multiple federal healthcare agencies, including extensive indefinite delivery contracts with the Department of Veterans Affairs valued at over $39 million through 2029–2030. The Indian Health Service has awarded Cepheid multiple contracts for diagnostic supplies and testing capabilities to support tribal healthcare operations, positioning this current purchase order as part of the company's ongoing support for infectious disease detection, including COVID-19, influenza, respiratory syncytial virus, and other clinical diagnostics across federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.0k | 4/22/26 |